Reducing human suffering by detecting cancer earlier with patented technology

BioCurex's RECAF(tm) marker is found in all types of major cancers

Free
Message: News

News

posted on Feb 19, 2009 03:36AM

19-Feb-2009

Change in Directors or Principal Officers




Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 17, 2009, Dr. Gerald Wittenberg resigned as the Company's Principal Financial Officer, Principal Accounting Officer, Secretary, Treasurer and as a director of the Company. Dr. Wittenberg had no disagreements with the Company on any matter relating to the Company's operations, policies or practices.

On February 18, 2009 Dr. Ricardo Moro was appointed the Company's Principal Financial Officer, Principal Accounting Officer, Secretary and Treasurer.

Dr. Moro remains as the Company's Chief Executive Officer and a director.




Feb 19, 2009 04:57PM
Share
New Message
Please login to post a reply